全文获取类型
收费全文 | 1181篇 |
免费 | 65篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 43篇 |
妇产科学 | 7篇 |
基础医学 | 135篇 |
口腔科学 | 9篇 |
临床医学 | 84篇 |
内科学 | 257篇 |
皮肤病学 | 12篇 |
神经病学 | 20篇 |
特种医学 | 317篇 |
外国民族医学 | 1篇 |
外科学 | 134篇 |
综合类 | 12篇 |
预防医学 | 33篇 |
眼科学 | 4篇 |
药学 | 117篇 |
中国医学 | 1篇 |
肿瘤学 | 45篇 |
出版年
2022年 | 4篇 |
2021年 | 14篇 |
2020年 | 4篇 |
2018年 | 11篇 |
2017年 | 5篇 |
2016年 | 9篇 |
2015年 | 13篇 |
2014年 | 9篇 |
2013年 | 14篇 |
2012年 | 14篇 |
2011年 | 24篇 |
2010年 | 20篇 |
2009年 | 21篇 |
2008年 | 22篇 |
2007年 | 35篇 |
2006年 | 29篇 |
2005年 | 22篇 |
2004年 | 19篇 |
2003年 | 21篇 |
2002年 | 27篇 |
2001年 | 26篇 |
2000年 | 25篇 |
1999年 | 35篇 |
1998年 | 56篇 |
1997年 | 45篇 |
1996年 | 65篇 |
1995年 | 45篇 |
1994年 | 39篇 |
1993年 | 42篇 |
1992年 | 21篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 47篇 |
1988年 | 48篇 |
1987年 | 41篇 |
1986年 | 35篇 |
1985年 | 51篇 |
1984年 | 32篇 |
1983年 | 30篇 |
1982年 | 29篇 |
1981年 | 28篇 |
1980年 | 15篇 |
1979年 | 6篇 |
1978年 | 10篇 |
1977年 | 36篇 |
1976年 | 20篇 |
1975年 | 19篇 |
1973年 | 6篇 |
1971年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有1268条查询结果,搜索用时 15 毫秒
1.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献
2.
3.
4.
5.
D Machover E Goldschmidt P Chollet G Metzger J Zittoun M Benavides J Marquet J M Vandenbulcke J L Misset L Schwarzenberg 《NCI monographs : a publication of the National Cancer Institute》1987,(5):193-198
We report the results of an expanded trial of 5-fluorouracil (FUra) combined with high-dose folinic acid for treatment of patients with advanced colorectal or gastric adenocarcinoma. In each treatment course, the patients received both FUra (340-400 mg/m2/day by iv infusion over 15 minutes) and folinic acid (200 mg/m2/day by iv bolus) for 5 consecutive days, with a 21-day interval between courses. Eighty-six patients with colorectal carcinoma were evaluated. The combined complete response (CR) and partial response (PR) rates were 39% for 54 patients who did not receive prior chemotherapy and 22% for 32 patients who had previously received chemotherapy. Four patients who were previously resistant to FUra attained objective responses. The median time to disease progression for the 28 responders was 10 months. The median survival time of responders was 19.5 months, and the probability of their being alive at 2 years was 40%. Of 27 patients with gastric adenocarcinoma, 13 (48%) responded to therapy. Their median time to disease progression was 5.5 months. The median survival time of responders was 11 months, and their probability of being alive at 15 months was 30%. Toxicity was within acceptable limits. Toxic effects included stomatitis, diarrhea, conjunctivitis, skin rash, and mild myeloid hypoplasia. In a separate study, plasma concentrations of L-folates above 10(-5) M were achieved after a rapid single iv injection of 200 mg/m2 of folinic acid.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
6.
Christiane Knoop Philippe Thiry Franck Saint-Marcoux Annick Rousseau Pierre Marquet Marc Estenne 《American journal of transplantation》2005,5(6):1477-1482
In cystic fibrosis (CF), absorption of tacrolimus through the gastrointestinal tract may be impaired due to fat malabsorption. The aim of this pilot study was to compare tacrolimus pharmacokinetics and inter- and intrasubject variability of exposure in stable lung transplant recipients with and without CF, and to determine the best single-time predictors of exposure. The study included 11 lung transplant recipients with CF and 11 without CF who received tacrolimus twice daily. Blood samples were obtained predose and at 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8 and 12 h postdose on 3 separate days within 1 week. Tacrolimus pharmacokinetics and inter- and intrasubject variability of exposure were similar in the two groups, though exposure-per-milligram-dose was approximately 50% lower in CF patients. Tacrolimus trough concentration did not accurately predict the area under the concentration curve (AUC(0-12)), but the concentration measured 3 h postdose (C(3)) was tightly correlated with the AUC(0-12) in both CF (r(2)= 0.86) and non-CF (r(2)= 0.92) patients. In summary, patients with CF have a higher tacrolimus oral clearance, but nonsignificant differences in short-term inter- and intrasubject variability of exposure compared to patients without CF. C(3) is tightly correlated with AUC(0-12) in lung transplant recipients with and without CF. 相似文献
7.
8.
Consequences of blood loss on growth of artificial metastases 总被引:2,自引:0,他引:2
S K Singh R L Marquet R W de Bruin W C Hop D L Westbroek J Jeekel 《The British journal of surgery》1988,75(4):377-379
Previous studies have shown that lung metastases from a nonimmunogenic sarcoma (LS175) in BN (homozygous for RTln) rats were stimulated by blood transfusions. Enhanced growth was also observed after abdominal surgery combined with allogeneic blood transfusions while syngeneic blood transfusions had no effect. These experimental findings have been confirmed in retrospective clinical studies. The allogeneic blood transfusion effect may be avoided in cancer patients by autologous blood transfusions although this implies blood donation before surgery. The aim of the present study was to investigate the effect of blood loss before surgery on formation ('take') of lung colonies, and on the outgrowth of established metastases in the BN rat model. These aspects of tumour behaviour were also investigated in rats undergoing surgery, or receiving blood transfusion, or both, after blood loss. The results indicate that blood loss has a profound stimulating effect on the growth of established metastases, but not on the 'take' of tumour cells. This stimulating effect was also present when blood loss was combined with surgery, while previously surgery alone was found to have no effect. Allogeneic and syngeneic transfusions in combination with blood loss both had a strong stimulating effect on growth of established lung metastases. The results indicate that blood loss may be an important factor in determining the outcome of metastatic growth. 相似文献
9.
10.